Mirum Pharmaceuticals, Inc.

NASDAQ:MIRM

44.56 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -87.942-163.415-135.665-83.988-103.27-52.553-17.348
Depreciation & Amortization 23.62910.8293.6810.9750.6230.3240
Deferred Income Tax 00-6.580.5950.07200
Stock Based Compensation 48.44435.02327.00723.08712.5546.070.051
Change In Working Capital 22.591-22.64-21.0516.9830.6117.1232.437
Accounts Receivables -11.426-43.974-20.7270000
Inventory -3.166-4.393-3.448-0.495000
Accounts Payables 40.31230.7787.63922.6553.68310.0582.449
Other Working Capital -3.129-5.051-4.514-5.177-3.072-2.935-0.012
Other Non Cash Items 3.60369.25912.471-90.410.335-0.32612.089
Operating Cash Flow 10.325-70.944-120.136-132.758-89.075-39.362-0.373
Investing Activities:
Investments In Property Plant And Equipment -0.993-0.109-0.278-19.024-0.225-0.281-7.5
Acquisitions Net 0-212.762-7.978-19-38.099127.50
Purchases Of Investments -89.026-27.329-132.322-198.029-74.562-1520
Sales Maturities Of Investments 19.894153140.3157.6112.66124.50
Other Investing Activites -20-207.97812738.099-127.5-11.25
Investing Cash Flow -90.125-107.27.748.54737.874-127.781-7.5
Financing Activities:
Debt Repayment 0305.30400000.05
Common Stock Issued 17.699216.684107.3676.914131.87167.259.786
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 17.699-185.3881.7266.55249.41759.9770
Financing Cash Flow 17.699336.6109.08773.466181.288127.17759.836
Other Information:
Effect Of Forex Changes On Cash -1.297-0.1330.012-0.0010.029-0.0270
Net Change In Cash -63.398158.323-3.337-10.746130.116-39.99351.963
Cash At End Of Period 222.928286.326128.003131.34142.08611.9751.963